eFFECTOR Therapeutics Inc... (EFTRW)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Oct 16, 2024, 3:18 PM

eFFECTOR Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	15.51M	14.88M	5.39M	14.71M	10.31M	8.71M	11.9M	16.35M	17.66M	49.7M	54.77M	10.88M	16.77M	15.22M	-3.43M
Short-Term Investments	9.88M	3.5M	12.39M	10.3M	8.7M	17.6M	21.05M	24.68M	28.04M	n/a	n/a	n/a	n/a	n/a	6.85M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	175.01M	n/a	n/a	n/a
Other Long-Term Assets	466K	513K	567K	615K	723K	711K	759K	807K	854K	903K	950K	-172.83M	56K	n/a	-3.43M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	500K	1.4M	n/a	n/a
Inventory	n/a	n/a	-23K	-72K	n/a	n/a	-400K	-400K	n/a	-100K	-200K	1.00	n/a	n/a	n/a
Other Current Assets	867K	1.47M	1.5M	956K	1.89M	1.7M	n/a	1.25M	2.63M	3.19M	n/a	1.15M	-1.18M	n/a	n/a
Total Current Assets	26.25M	19.84M	19.28M	25.98M	20.89M	28.01M	35.52M	42.28M	48.34M	52.9M	58.94M	12.03M	17M	16.58M	3.43M
Property-Plant & Equipment	415K	193K	312K	299K	311K	352K	371K	381K	302K	257K	45K	68K	97K	126K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	881K	706K	879K	914K	1.03M	1.06M	1.13M	1.19M	1.16M	1.16M	995K	2.25M	153K	126K	-3.43M
Total Assets	27.13M	20.54M	20.16M	26.89M	21.93M	29.08M	36.65M	43.47M	49.49M	54.06M	59.94M	14.28M	17.15M	16.7M	n/a
Account Payables	1.71M	2.33M	1.14M	1.45M	3.79M	1.49M	1.21M	1.2M	294K	516K	321K	1.91M	458K	347K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-54K	n/a	n/a	n/a	2.75M	2.66M	351K	1.98M	n/a
Short-Term Debt	20.02M	20.48M	20.4M	20.32M	20.24M	20.16M	20.09M	20.01M	46K	44K	28K	55K	18.56M	5.91M	n/a
Other Current Liabilities	978K	1.59M	1.21M	946K	680K	1.39M	1.07M	597K	542K	1.3M	44.02M	780K	3.2M	663K	n/a
Total Current Liabilities	25.57M	25.8M	23.59M	23.76M	26.65M	25.07M	24.97M	23.59M	2.63M	3.98M	46.35M	5.4M	22.57M	8.78M	n/a
Long-Term Debt	n/a	n/a	6K	25K	n/a	n/a	77K	94K	19.92M	19.86M	19.76M	19.67M	n/a	6.95M	n/a
Other Long-Term Liabilities	556K	543K	527K	505K	46K	46K	-31K	75K	1.61M	12.81M	1.5M	133.22M	n/a	133.22M	n/a
Total Long-Term Liabilities	735K	543K	539K	555K	89K	106K	123K	263K	21.63M	32.79M	21.26M	152.89M	10.24M	140.17M	n/a
Total Liabilities	26.3M	26.34M	24.13M	24.31M	26.74M	25.18M	25.09M	23.85M	24.26M	36.77M	67.61M	158.29M	22.57M	148.95M	n/a
Total Debt	20.25M	19.45M	20.48M	20.41M	20.35M	20.28M	20.22M	20.15M	20.07M	20.03M	19.79M	19.72M	18.56M	12.96M	n/a
Common Stock	n/a	n/a	6K	6K	4K	n/a	4K	4K	4K	4K	4K	2K	1K	454.00	n/a
Retained Earnings	-188.21M	-179.38M	-170.25M	-161.94M	-153.58M	-143.57M	-134.31M	-124.75M	-117.83M	-120.9M	-139.95M	-148.83M	-143.28M	-136.7M	n/a
Comprehensive Income	n/a	0.00	-1K	1K	1K	-18K	-69K	-82K	-50K	-0.00	-59.94M	-133.22M	-999	-133.22M	-147.06M
Shareholders Equity	827K	-5.79M	-3.97M	2.58M	-4.81M	3.9M	11.56M	19.62M	25.23M	17.28M	-7.67M	-144.01M	-5.42M	-132.25M	-13.84M
Total Investments	9.88M	3.5M	12.39M	10.3M	8.7M	17.6M	21.05M	24.68M	28.04M	n/a	n/a	175.01M	n/a	n/a	6.85M